Tolazamide: Difference between revisions

Tolazamide
	Error creating thumbnail: File missing
Clinical data
[[Regulation of therapeutic goods \|Template:Engvar data]]	US FDA: Tolazamide;
Pregnancy; category	AU: C ; US: C (Risk not ruled out) ; ;
Routes of; administration	Oral
ATC code	A10BB05 (WHO) ;
Legal status
Legal status	US: ℞-only ;
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Elimination half-life	7 hours
Excretion	Renal (85%) and fecal (7%)
Identifiers
	IUPAC name 3-azepan-1-yl-1-(4-methylphenyl)sulfonyl-urea;
CAS Number	1156-19-0;
PubChem CID	5503;
DrugBank	APRD01267;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C14H21N3O3S
Molar mass	311.401 g/mol

Revision as of 16:57, 20 August 2012

{{SIB} For patient information, click here

Tolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes. It is part of the sulfonamide family (ATC A10BB).

@@ Line 1: / Line 1: @@
-{{Editor Help}}
 {{Drugbox|
@@ Line 29: / Line 29: @@
 * [http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682482.html NIH/Medline]
-{{SIB}}
 {{Oral_hypoglycemics}}
 [[Category:Endocrinology]]

Clinical data
Error creating thumbnail: File missing
[[Regulation of therapeutic goods \|Template:Engvar data]]	US FDA: Tolazamide
Pregnancy category	AU: C US: C (Risk not ruled out)
Routes of administration	Oral
ATC code	A10BB05 (WHO)
Legal status
Legal status	US: ℞-only
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Elimination half-life	7 hours
Excretion	Renal (85%) and fecal (7%)
Identifiers
IUPAC name 3-azepan-1-yl-1-(4-methylphenyl)sulfonyl-urea
CAS Number	1156-19-0
PubChem CID	5503
DrugBank	APRD01267
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₁₄H₂₁N₃O₃S
Molar mass	311.401 g/mol